SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-024987
Filing Date
2016-07-12
Accepted
2016-07-12 17:01:29
Documents
1
Period of Report
2016-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4008
  Complete submission text file 0000899243-16-024987.txt   5471
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O PROTINE DESIGN LAB 34801 CAMPUS DR FREEMONT CA 94555
Business Address
EBERSOLE DOUGLAS O (Reporting) CIK: 0001242112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 161764424